About the AR Lab Network
Laboratory tests can help guide patient treatment, detect emerging threats, and prevent the spread of antibiotic resistance. CDC’s AR Lab Network supports nationwide lab capacity to rapidly detect antibiotic resistance and inform local responses to prevent spread and protect people.
The network closes the gap between local capabilities and the data needed to combat antibiotic resistance by providing:
- Comprehensive lab capacity and infrastructure for antibiotic-resistant pathogens
- Cutting-edge technology, like DNA sequencing
- Data to drive response and prevent infections
The AR Lab Network includes labs in 50 states, four cities, and Puerto Rico, including seven regional labs and the National Tuberculosis Molecular Surveillance Center (National TB Center).
chat icon How Labs Work Together
Read how labs collaborate across the local to national levels.
lab icon How to Participate: Lab Testing
Find a summary and descriptions of lab tests, submission details, and testing availability by regional lab.
lab icon What CDC is Doing
Learn how CDC is addressing lab capacity to combat antibiotic resistance.
medical icon CDC and FDA AR Isolate Bank
Order isolates or read about innovation in diagnostics and drug development.
National Tuberculosis Molecular Surveillance Center:
- Michigan Department of Health and Human Services (Lansing, MI)